Forte Biosciences, Inc. Share Price & Technical Analysis
FBRX · $21.94 (+1.62%)
Healthcare / Biotechnology
$21.94
+1.62%
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dalla…
Price chart
Bearish · Downtrend · Weak
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$503.98M
P/E ratio
—
52W high
$35.80
52W low
$7.78
Volume
2,03,599
Beta
3.00
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Forte Biosciences, Inc. share price today?
- Forte Biosciences, Inc. (FBRX) last traded around $21.94 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does FBRX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for FBRX. Download the app for real-time alerts.
- How can I analyze Forte Biosciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.